Medication Assisted Treatment and Pregnancy

Slides:



Advertisements
Similar presentations
and alcohol dependence
Advertisements

Neonatal Abstinence Syndrome: Taking Care of Mom and Baby Heather Rodman, PharmD PGY-2 Pediatric Pharmacy Resident Peyton Manning Children’s Hospital St.
Effective Risk Management Strategies in Outpatient Methadone Treatment: Clinical Guidelines and Liability Prevention Curriculum Module 9 Special Populations.
Neonatal Abstinence Syndrome: A Family Centered Approach to Care Kelly Outlaw, M.S., CCLS.
Fact sheet Policies and Programs to Address Drug-Exposed Newborns The use or abuse of either illegal or prescription drugs during pregnancy can have serious.
Moms on Meds Substance Abuse During Pregnancy: Jennifer Anderson Maddron, M.D.
Oct. 1,  361 Depression  381 Oral Health Conditions  411 Inappropriate Nutrition Practices Infants  New 334 Lack of or Inadequate Prenatal Care.
V.Sideri, C.Vliora, A.Daskalaki, P.Mexi-Bourna, K.Kleanthous, M.Soulioti, G. Kyrkou, N.Bournas, V.Papaevangelou 3 rd Pediatric Clinic of the University.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, Deputy Director Andrea Boxill, Deputy Director Governor’s Cabinet Opiate Action Team.
Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence Implementing NICE guidance February 2011 NICE clinical.
Children Birth 4. Childbirth Setting And Attendants 99% of U.S. births occur in hospitals Other options –Freestanding birth center, home delivery Who.
1 Presentation to:Care Management Committee Presented by: Janice Carson, MD Deputy Director, PQO Date: 04/09/15 Performance Measurement.
Implementing a Rapid HIV Testing Guideline for L&D NNEPQIN April 30, 2007.
For Pain or Not for Pain: Methadone Madness
Current Trends In Identifying And Treating Newborns With Withdrawal Syndromes 6/24/2010.
1 Breastfeeding Promotion in NICU Z. Mosayebi Neonatologist, Tehran University of Medical Sciences.
Drug Treatment Issues in Drug-Dependent, Pregnant Women Hendrée E. Jones, Ph.D. Department of Psychiatry and Behavioral Sciences Johns Hopkins University.
 John McCarthy, M.D.  Executive/Medical Director, Bi-Valley Medical Clinic, Sacramento.
Pregnancy and Drug Abuse Eva Janecek-Rucker. Learning Objectives 1.To develop a knowledge base of the effects of substances of abuse (e.g., alcohol, cocaine,
Module IV: Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals.
Treating Pregnant Opioid Dependent Women: Examining Buprenorphine and Methadone Hendrée E. Jones, Ph.D. Associate Professor Department of Psychiatry and.
Improving Care for Opioid Exposed Newborns September 11, 2006 NNEPQIN Dartmouth Hitchcock Medical Center Anne Johnston, MD Associate Professor of Pediatrics.
Treatment of Opioid Dependency in Pregnancy and Strategies to Reduce Neonatal Abstinence Syndrome.
Don Teater MD Medical Advisor National Safety Council Itasca, IL Medical Provider Behavioral Health Group Asheville, NC Medical Provider Meridian Behavioral.
The Problem of Neonatal Abstinence Syndrome (NAS) Opiates and Pregnancy.
Abusing Drugs During Pregnancy is Child Abuse Hannah Magyar CP English 12 Mrs. Mahoney May 5, 2015.
Neonatal Abstinence Syndrome: Preserving the Infant-Maternal Bond Haneme Idrizi, MD, FAAP Assistant Professor of Pediatrics, University of Texas Health.
Neonatal Abstinence Syndrome
Rika Dombrowski PHN, MS, MA, IBCLC. Among pregnant women years of age in U.S, -5.2% had used illicit drugs in the past month. -9.4% Alcohol use.
Specific issues in drug use and pregnancy. Pregnant women who use drugs (RCOG, 2010) One of the challenges for pregnant women who use drugs is that they.
Care of the Neonate with Prenatal Opioid Exposure – Advanced Practice
Terms Related to Substance Abuse
Medication Assisted Treatment and Pregnancy
Substance Exposed Newborns: Addressing Substance Use Disorder
Medication Assisted Treatment
Breastfeeding Promotion in NICU
Medication Assisted Treatment
Clinical Opiate Withdrawal – Symptom Management Protocol
Special Populations: Opioids and OB Patients(1)
Neonatal Abstinence Syndrome (NAS) Program Overview
Neonatal Abstinence Syndrome: An emerging issue for Part C systems?
Alcohol, Other Drugs, and Health: Current Evidence
PET Scan -Increased FDG uptake PET Scan -Decreased FDG uptake
Maternal Toxicity Management
Improving Care for Opioid-Exposed Newborns
Delaware Dialogue: Addressing Substance Abuse DHMIC Summit 2017
High Risk neonatal nursing
Neonatal abstinence syndrome management: A quality improvement initiative to educate caregivers, & providers in the outpatient setting Nguyen J, MD*. Chau.
What’s New in the Perinatal Guidelines
OPIOID SAFETY. Indiana Statistics In Summary… About 100 Hoosiers die from drug overdoses every month, many from opioids such as heroin and prescription.
Neonatal Abstinence Syndrome
Neonatal Abstinence Syndrome
WHO recommendations on interventions to improve preterm birth outcomes
Significance to Nursing
MDHHS Response to the Opioid Crisis
WisPQC Standardized Protocol Webinar for NAS/NOWS Initiative
West Virginia Medicaid Summit
Intro to Maternity Nursing
BoRN ADDICTED: Neonatal Abstinence syndrome
Welcome West Virginia Perinatal Partnership
30-40% of pregnant women receive opioid
Jonathan Davis, MD Chief of Newborn Medicine
What healthcare services are covered by insurance?
Mommies Program – Outpatient Treatment NAS Residential Treatment
Case 1 – 17 yo white female 2 year history of using opioids – prescription post minor surgery, continued use post prescription (non-medical sources) –
The Judicial Branch’s Response to the Opioid Crisis
Medically assisted treatment
Neonatal Abstinence Syndrome Survey
Treating and Managing Opioid Use Disorder in Pregnancy
Dr. Sarah Fernandez PGY4 NOSM, Pediatrics, Thunder Bay Campus
Presentation transcript:

Medication Assisted Treatment and Pregnancy

Identifying Pregnant Women in MAT Pregnancy Testing Sharing Results Locating Prenatal Care Methadone Friendly OB/GYN

Patient Education Mommy's Emotional State Counselor Education and Training Medical Director  Policy Procedure

Medication Increase and Decrease Methadone and Baby Methadone and Mommy Medical Staff (The Clinic and the OB/GYN) Counseling Split Dosing

Trimesters 1st Trimester – Education, Morning Sickness (Zofran)and Reassurance  2nd Trimester – Dose Stability and Prenatal Follow Up 3rd Trimester – Due Date, C Section or Natural Birth

Preparing for Delivery Takeout Medication Hospital Admission Contact with Nursing Staff MAT Education

What is NAS NAS – Neonatal Abstinence Syndrome Neonatal withdrawal after exposure to certain drugs illicit or prescription  Newborns reframing from a group of symptoms that consistently occur together or a combination of symptoms (Chills, mild tremors, server crying, sleeping pattern, losses stools, feeding patterns, nasal sniffing ) 1% of pregnant women in the US are found using illicit opioids Morphine or Methadone is the standard of care in the US for opioid dependent women Buprenorphine is being use as an alternative but is not approved in the US Presenting symptoms occurs with the first 48 to 72 hours after birth. 55% to 95% of infants are exposed   

NAS Scoring Scale The Finnegan Neonatal Abstinence Scoring System 31 itam scale design to quantify severity of NAS and NAS treatment Begins scoring within 2 hours of life  Administer every 3 to 4 hours  NAS symptoms are weighed numerically scoring 1 – 5 Infants scoring 8 or greater will receive pharmacological therapy Very comprehensive but to complex for routine use

Babies Treatment  Three reason medication is adminstered in the hospital  1.  Respiratory depression requires inpatient monitoring  2.  Relapse Prevention  3.  Frequent assessment by trained providers for either over or under medicate  4.  Length of stay 30 to 40 days  Methadone Half Life in newborns 3.8 to 62 hours but it's difficult to gauge in newborns     

Medications Used 20% of providers use methadone 63% Use other opioids Initial theropy use alcohol free oral morphine sulfate 0.4 mg/mL or preprartion morphine hydrochloride 0.2 mg/mL  Diluted Tincture of opium(Contains a small amount of alcohol) Paregoric 1st agent used but decclided due to toxic side effects Diazepam no longer used due to impaired neonatal excretion and late on set seizures  

Postpartum Depression and Anxiety Baby Assessment Supporting Mommy DFACS 1. 

Benfits or Purpose for Treatment To Prevent Opioid Withdrawal Signs and Symptoms To Provide a Safe and Comfortable Induction/Education Block the Euphoric Effects of Illicit Opioids Eliminating the Fetal Exposure to Opioids

Talking to Family and Loved Ones Educate – On Methadone Educate – On Pregnancy and Methadone Educate – On Our Baby Educate – On What to expect

Research The Opioid Exposed Newborn: Assessment and Pharmacologic Management Lauren M. Jansson, Martha Velez, Cheryl Harrow J Opioid Manag. Author manuscript; available in PMC 2009 August 19. Published in final edited form as: J Opioid Manag. 2009; 5(1): 47–55. Neonatal Abstinence Syndrome: Influence of a Combined Inpatient/Outpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population Jerry Lee, Sonia Hulman, Michael Musci, Jr., Ellen Stang Popul Health Manag. 2015 October 1; 18(5): 392–397. doi: 10.1089/pop.2014.0134

Research Continued  Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Children’s Hospital -2/11/13      Revised: 02/2013 by Sarah Tierney, PharmD. Written: 09/2012 by Sarah            Tierney, PharmD Approved: 09/2012 J Klein MD